¿pueden las enfermedades médicas causar depresión?

¿Pueden las enfermedades médicas causar depresión?

Kanner AM. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry. 2003;54(3):388-398. Lambert MV, Robertson MM. Depression in epilepsy: etiology, phenomenology, and treatment. Epilepsia. 1999;40(suppl 10): S21-S47. Patten SB, Neutel CI. Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf. 2000;22(2):111-122. Asnis GM, De La Garza R 2nd. Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology and treatment approaches. J Clin Gastroenterol. 2006;40(4):322-335. Goeb JL, Even C, Nicolas G, et al. Psychiatric side effects of interferon-beta in multiple sclerosis. Eur Psychiatry. 2006;21(3):186-193. Hull PR, D’Arcy C. Isotretinoin use and subsequent depression and suicide: presenting the evidence. Am J Clin Dermatol. 2003;4(7):493-505. U.S. Food and Drug Administration. Information for Healthcare Professionals: Varenicline (marketed as Chantix) and Bupropion (marketed as Zyban, Wellbutrin, and generics). Drug SafetyIn formation for Heath care Professionals/ ucm169986.htm. Accessed July 7, 2009. Larisch R, Kley K, Nikolaus S, et al. Depression and anxiety in different thyroid function states. Horm Metab Res. 2004;36(9):650-653. Pop VJ, Maartens LH, Leusink G, et al. Are autoimmune thyroid dysfunction and depression related? J Clin Endocrinol Metab. 1998;83(9):3194-3197. Gold MS, Pottash AL, Extein I. Hypothyroidism and depression. Evidence from complete thyroid function evaluation. JAMA. 1981;245(19):1919-1922. Joffe RT, Singer W, Levitt AJ, et al. A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression. Arch Gen Psychiatry. 1993;50(5):387-393. Wilhelm SM, Lee J, Prinz RA. Major depression due to primary hyperparathyroidism: a frequent and correctable disorder. Am Surg. 2004;70(2):175-179. Sonino N, Fava GA. Psychiatric disorders associated with Cushing’s syndrome. Epidemiology, pathophysiology, and treatment. CNS Drugs. 2001;15(5):361-373. Sonino N, Fava GA, Raffi AR, et al. Clinical correlates of major depression in Cushing’s disease. Psychopathology. 1998;31(6):302-306. Dorn LD, Burgess ES, Dubbert B, et al. Psychopathology in patients with endogenous Cushing’s syndrome: ‘atypical’ or melancholic features. Clin Endocrinol (Oxf). 1995;43(4):433-442. Zeiger MA, Fraker DL, Pass HI, et al. Effective reversibility of the signs and symptoms of hypercortisolemia by bilateral adrenalectomy. Surgery. 1993;114(6):1138-1143. Thomsen AF, Kvist TK, Andersen PK, et al. The risk of affective disorders in patients with adrenocortical insuffi ciency. Psychoneuroendocrinology. 2006;31(5):614-622. Gainotti G, Azzoni A, Marra C. Frequency, phenomenology and anatomical-clinical correlates of major post-stroke depression. Br J Psychiatry. 1999;175:163-167. Newberg AR, Davydow DS, Lee HB. Cerebrovascular disease basis of depression: post-stroke depression and vascular depression. Int Rev Psychiatry. 2006;18(5):433-441. Hughes J, Devinsky O, Flemann E, et al. Premonitory symptoms in epilepsy. Seizure. 1993;2(3):201 203. Shoenfeld M, Myers RH, Cupples RA, et al. Increased rate of suicide among patients with Huntington’s disease. J Neurol Neurosurg Psychiatry. 1984;47(12):1283-1287. Tost H, Wendt CS, Schmitt A, et al. Huntington’s disease: phenomenological diversity of a neuropsychiatric condition that challenges traditional concepts in neurology and psychiatry. Am J Psychiatry. 2004;161(1):28-34. Rosenblatt A. Neuropsychiatry of Huntington’s disease. Dialogues Clin Neurosci. 2007;9(2):191-197. Paulsen JS, Ready RE, Hamilton JM, et al. Neuropsychiatric aspects of Huntington’s disease. J Neurol Neurosurg Psychiatry. 2001;71(3):310-314. Anderson KE. Huntington’s disease and related disorders. Psychiatry Clin North Am. 2005;28(1):275 290. Loudianos G, Gitlin JD. Wilson’s disease. Semin Liver Dis. 2000;20(3):353-364. Chwastiak L, Ehde DM, Gibbons LE, et al. Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry. 2002;159(11):1862-1868. Feinstein A. The neuropsychiatry of multiple sclerosis. Can J Psychiatry. 2004;49(3):157-163. Siegert RJ, Abernethy DA. Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry. 2005;76(4):469-475. Feinstein A, Roy P, Lobaugh N, et al. Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology. 2004;62(4):586-590. McDonald WM, Richard IH, DeLong MR. Prevalence, etiology and treatment of depression in Parkinson’s disease. Biol Psychiatry. 2003;54(3):363-375. Lyketsos CG, Kozauer N, Rabins PV. Psychiatric manifestations of neurologic disease: where are we headed? Dialogues Clin Neurosci. 2007;9(2):111-124. Rosenblatt A, Leroi I. Neuropsychiatry of Huntington’s disease and other basal ganglia disorders. Psychosomatics. 2000;41(1):24-30. Penzak SR, Reddy YS, Grimsley SR. Depression in patients with HIV infection. Am J Health Syst Pharm. 2000;57(4):376-386. Basu S, Chwastiak LA, Bruce RD. Clinical management of depression and anxiety in HIV-infected adults. AIDS. 2005;19(18):2057-2067. Gibbie T, Mijch A, Ellen S, et al. Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year followup. HIV Med. 2006;7(2):112-121. Ammassari A, Antinori A, Aloisi MS, et al. Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics. 2004;45(5):394-402. Murray KO, Resnick M, Miller V. Depression after infection with West Nile virus. Emerg Infect Dis. 2007;13(3):479-481. Elkins LE, Pollina DA, Scheffer SR, et al. Psychological states and neuropsychological performances in chronic Lyme disease. Appl Neuropsychol. 1999;6(1):19-26. Sanchez FM, Zisselman MH. Treatment of psychiatric symptoms associated with neurosyphilis. Psychosomatics. 2007;48(5):440-445. Carta MG, Hardoy MC, Garofalo A, et al. Association of chronic hepatitis C with major depressive disorders: irrespective of interferon-alpha therapy. Clin Pract Epidemol Ment Health. 2007;3:22. Wessely S, Pariante C. Fatigue, depression and chronic hepatitis C infection. Psychol Med. 2002;32(1):1-10. Dieperink E, Ho SB, Thuras P. A prospective study of neuropsychiatry symptoms associated with interferon-alpha- 2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics. 2003;44(2):104-112. Carney CP, Jones L, Woolson RF, et al. Relationship between depression and pancreatic cancer in the general population. Psychosom Med. 2003;65(5):884-888. Farrugia ME, Conway R, Simpson DJ, et al. Paraneoplastic limbic encephalitis. Clin Neurol Neurosurg. 2005;107(2):128-131. Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological fi ndings, and tumor association in 50 patients. Brain. 2000;123(pt 7):1481-1494.

Source: http://www.intramed.net/userfiles/file/%C3%82%C2%BFPueden%20las%20enfermedades%20m%C3%83%C2%A9dicas%20causar%20depresi%C3%83%C2%B3n_.pdf


Quarantine Requirements for the Importation of Frozen Canine Semen (In case of any discrepancy between the English version and the Chinese text of these Requirements, the Chinese text shall govern) Promulgated by Council of Agriculture on March 14, 2007 1. Only the registered veterinary medical institutions/clinics or their agencies can apply for the importation of canine semen. Before the imp

Microsoft word - cnrs-21_johnson.doc

Proceedings of the HYDRALAB III Joint User Meeting, Hannover, February 2010 NEAR-CRITICAL OROGRAPHIC FORCING OF STRATIFIED FLOW E.R.Johnson(1), J.G.Esler(2), A. Paci(3), S. Cazin(4), E. Cid(4), O. Eiff(4) & L. Lacaze(4) (1) Department of Mathematics, UCL, U.K., E-mail: e.johnson@ucl.ac.uk (2) Department of Mathematics, UCL, U.K., E-mail: gavin@math.ucl.ac.uk (3) CNRM-GAME (URA1357

© 2010-2014 Pdf Medical Search